Richardson Financial Services Inc. Ligand Pharmaceuticals Inc Call Options Transaction History
Richardson Financial Services Inc.
- $161 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
305Shares Held
20MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$598 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$432 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$221 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$193 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$156 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.52B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...